Described by clients as ‘very friendly, supportive, and proactive’, Penningtons Manches Cooper LLP has strong expertise in R&D agreements, IP contracts, and image rights issues associated with the advertising sphere. The group also has experience assisting with venture capital funding work for therapeutics start-ups. The team is led from Birmingham by Lisa Page, who specialises in the life science and biotech industries.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Penningtons seems to be able to offer true value for money, with much hands-on involvement from knowledgeable and experienced partners with quality that is comparable to City law firms and at rates that are much more palatable than what those City law firms think they should be able to charge.'
- 'Very friendly, supportive, and proactive interactions. Fair budgets, good communication, and proactive efforts to stay within agreed budgets.’
‘Lisa Page was able to provide not only excellent legal support, she also was able to draw on her previous experience working for a CRO. She was knowledgeable both on points of law and market practice, communicative, friendly, supportive, and actively helped us manage our budget. During negotiations, she was pragmatic and able to make us focus on what for us were the most material points in the big picture. I wish it was easier to find more Lisas amongst our legal advisers across the world.'
Key clients
- The Advanced Research + Invention Agency
- Oxford Cannabinoid Technologies Limited
- SynOx Therapeutics Limited
- Pathios Therapeutics Limited
- Cranfield University
- Grey Wolf Therapeutics Limited
- Ethera Health Limited
- Enhanced Limited
- Cytecom Limited
Work highlights
Advised ARIA (The Advanced Research + Invention Agency ) as part of our appointment as sole legal advisors on the IP position in its grant funding agreements, its commercial R&D agreement, preclinical and clinical regulations for its research programmes and supported its trade mark filings and prosecution.
Supported M:MBio, trading as Molecule to Medicine on the IP rich agreements with its biotech ecosystem companies including bioinformatics and data licensing.
Assisted Enhanced Limited in the set-up of its agreement with athletes including IP and image rights and its clinical case series agreements for the Enhanced Games and world record attempts.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Lisa Page